VFIAX
Price
$716.34
Change
+$4.44 (+0.62%)
Updated
Aug 7 closing price
Net Assets
1.69T
WOGSX
Price
$178.44
Change
+$1.74 (+0.98%)
Updated
Aug 7 closing price
Net Assets
499.57M
Interact to see
Advertisement

VFIAX vs WOGSX

VFIAX vs WOGSX Comparison Chart in %
View a ticker or compare two or three
VS
VFIAX vs. WOGSX commentary
Aug 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VFIAX is a Buy and WOGSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.69T vs. WOGSX (500M). VFIAX pays higher dividends than WOGSX: VFIAX (1.06) vs WOGSX (0.44). VFIAX was incepted earlier than WOGSX: VFIAX (26 years) vs WOGSX (34 years). WOGSX (0.90) is less costly to investors than VFIAX (0.04). WOGSX is a more actively managed with annual turnover of: 11.00 vs. VFIAX (2.00). WOGSX has a lower initial minimum investment than VFIAX: WOGSX (2000) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 22.40 vs. WOGSX (19.72). VFIAX return over 5 years is better than : 75.02 vs. WOGSX (30.42).
VFIAXWOGSXVFIAX / WOGSX
Total Expense Ratio0.040.904%
Annual Report Gross Expense Ratio0.040.904%
Fund Existence26 years34 years-
Gain YTD13.39314.28294%
Front LoadN/AN/A-
Min. Initial Investment30002000150%
Min. Initial Investment IRAN/AN/A-
Net Assets1.69T500M337,400%
Annual Yield % from dividends1.060.44241%
Returns for 1 year22.4019.72114%
Returns for 3 years72.6543.05169%
Returns for 5 years75.0230.42247%
Returns for 10 years255.87176.74145%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LHSW2.960.17
+6.09%
Lianhe Sowell International Group Ltd
VMC284.693.06
+1.09%
Vulcan Materials Company(Holding Company)
CATY63.41-0.30
-0.47%
Cathay General Bancorp
BZH33.18-0.28
-0.84%
Beazer Homes USA
IPHA1.73-0.09
-4.95%
Innate Pharma SA